Nemolizumab is safe and effective for long-term use in patients with moderate-to-severe atopic dermatitis, an extension study ...
In a retrospective analysis of 151 cases, low level laser therapy achieved the highest satisfaction and perceived ...
The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...
A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
A new study published in the journal of BMC Surgery revealed that far lateral lumbar disc herniation (FLLDH) presents diagnostic and surgical challenges, but unilateral biportal ...
Among patients with metastatic cancer who are receiving oral targeted therapy, home-based supervised physical therapy has ...
Background The minimally important difference (MID) for frailty variation associated with adverse outcomes remains unknown in ...
Weekly hydrocolloid dressings were comparable to a daily petroleum-based regimen for patient-reported scar appearance after ...
Trigger finger (TF) causes pain and impaired hand function. Percutaneous release of the A1 pulley demonstrates a better outcome than steroid injection in the treatment of TF; however, ...
Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback